Letter to Industry, Powered Wheelchair Manufacturers from RMJohnson

Issue Date: May 10, 1993
Issued by: Center for Devices and Radiological Health
Topic(s):
Status: Final

Letter to Industry, Powered Wheelchair Manufacturers from RMJohnson

The Food and Drug Administration (FDA) has received reports of power-driven wheelchairs moving uncontrollably when in the presence of certain radio frequencies. The purpose of this letter is to alert you to this problem.

Download the Guidance Document

webmaster1993-05-10T00:00:00+00:00

ABOUT US

Avance Biosciences is a leading Contract Research Organization (CRO) and Contract Testing Organization (CTO) providing CGMP and GLP-compliant analytical and bioanalytical services to support drug development. From early discovery through clinical development and commercialization, we provide CGMP and GLP-compliant services tailored to your therapeutic modality and regulatory needs.